Editorial

Abstract

I am very pleased to announce that the Editorial Team for the Journal of Pharmaceutical Sciences (JPharmSci®) has decided to dedicate a future issue of the journal to Professor Leslie Z. Benet and to the science that he has loved and fostered throughout his professional career. This honor is being bestowed on Professor Benet because of the tremendous impact that he continues to have on research in pharmaceutical sciences; his longstanding commitment to teaching the next generation of pharmacy students, graduate students, postdoctoral fellows, and visiting scholars; his enthusiasm for mentoring young scientists; and his dedication to professional service in pharmaceutical sciences. Professor Benet is considered by his peers to be one of the “founding fathers” of the modern pharmaceutical sciences. His contributions to pharmaceutical sciences will be summarized in a Commentary to be published in this dedicated issue of JPharmSci®.Professor Benet has been recognized worldwide for decades as a leader in pharmaceutical sciences and clinical pharmacology. His scientific contributions have expanded our understanding of drug absorption, distribution, metabolism/transport, excretion, and toxicity (ADMET), and continue to have a major impact on the fields of pharmacokinetics, pharmacodynamics, biopharmaceutics, and drug delivery. Professor Benet's most recent work has addressed the interplay of metabolic enzymes and transport proteins, as they relate to oral bioavailability and hepatic elimination, and the development of the Biopharmaceutics Drug Disposition Classification System (BDDCS).Professor Benet's dedicated issue of JPharmSci® will include original scientific papers (Research Articles, Notes, and Rapid Communications), Reviews and Commentaries in the areas of ADMET, BDDCS, bioavailability, clinical pharmacology, drug delivery, drug–drug interactions, metabolic enzymes, transporters, pharmacokinetics/pharmacodynamics/pharmacometrics, and pharmacogenomics. In light of Professor Benet's many outstanding contributions to academia, industry, professional societies, regulatory agencies (e.g., US Food and Drug Administration), and the basic and clinical sciences (e.g., bioanalytical methodology, biomarkers, biotechnology product development, drug delivery technology, clinical trials, regulatory science, and translational medicine/research), Research Articles, Notes, Rapid Communications, and Reviews in all of these areas of the pharmaceutical sciences will also be considered for inclusion in this dedicated issue of JPharmSci®.In honor of Professor Benet's pioneering spirit, novel ideas or thought-provoking Commentaries that might open up new frontiers in the pharmaceutical sciences are also welcome.I am pleased to announce that Professors Emi Nakashima (Keio University, Minato, Tokyo), Kim L. R. Brouwer (University of North Carolina at Chapel Hill, Chapel Hill, North Carolina), Margareta Hammarlund-Udenaes (Uppsala University, Uppsala, Sweden), and Tetsuya Terasaki (Tohoku University, Sendai, Miyagi, Japan) have agreed to be Guest Editors for the issue of JPharmSci® dedicated to Professor Leslie Z. Benet.If you are interested in receiving an invitation to contribute a manuscript to this dedicated issue, thus honoring Professor Benet, please contact Professor Emi Nakashima (nakashima-em@pha.keio.ac.jp) for more details. It is anticipated that the issue dedicated to Professor Leslie Z. Benet will be published in September 2013. I am very pleased to announce that the Editorial Team for the Journal of Pharmaceutical Sciences (JPharmSci®) has decided to dedicate a future issue of the journal to Professor Leslie Z. Benet and to the science that he has loved and fostered throughout his professional career. This honor is being bestowed on Professor Benet because of the tremendous impact that he continues to have on research in pharmaceutical sciences; his longstanding commitment to teaching the next generation of pharmacy students, graduate students, postdoctoral fellows, and visiting scholars; his enthusiasm for mentoring young scientists; and his dedication to professional service in pharmaceutical sciences. Professor Benet is considered by his peers to be one of the “founding fathers” of the modern pharmaceutical sciences. His contributions to pharmaceutical sciences will be summarized in a Commentary to be published in this dedicated issue of JPharmSci®. Professor Benet has been recognized worldwide for decades as a leader in pharmaceutical sciences and clinical pharmacology. His scientific contributions have expanded our understanding of drug absorption, distribution, metabolism/transport, excretion, and toxicity (ADMET), and continue to have a major impact on the fields of pharmacokinetics, pharmacodynamics, biopharmaceutics, and drug delivery. Professor Benet's most recent work has addressed the interplay of metabolic enzymes and transport proteins, as they relate to oral bioavailability and hepatic elimination, and the development of the Biopharmaceutics Drug Disposition Classification System (BDDCS). Professor Benet's dedicated issue of JPharmSci® will include original scientific papers (Research Articles, Notes, and Rapid Communications), Reviews and Commentaries in the areas of ADMET, BDDCS, bioavailability, clinical pharmacology, drug delivery, drug–drug interactions, metabolic enzymes, transporters, pharmacokinetics/pharmacodynamics/pharmacometrics, and pharmacogenomics. In light of Professor Benet's many outstanding contributions to academia, industry, professional societies, regulatory agencies (e.g., US Food and Drug Administration), and the basic and clinical sciences (e.g., bioanalytical methodology, biomarkers, biotechnology product development, drug delivery technology, clinical trials, regulatory science, and translational medicine/research), Research Articles, Notes, Rapid Communications, and Reviews in all of these areas of the pharmaceutical sciences will also be considered for inclusion in this dedicated issue of JPharmSci®. In honor of Professor Benet's pioneering spirit, novel ideas or thought-provoking Commentaries that might open up new frontiers in the pharmaceutical sciences are also welcome. I am pleased to announce that Professors Emi Nakashima (Keio University, Minato, Tokyo), Kim L. R. Brouwer (University of North Carolina at Chapel Hill, Chapel Hill, North Carolina), Margareta Hammarlund-Udenaes (Uppsala University, Uppsala, Sweden), and Tetsuya Terasaki (Tohoku University, Sendai, Miyagi, Japan) have agreed to be Guest Editors for the issue of JPharmSci® dedicated to Professor Leslie Z. Benet. If you are interested in receiving an invitation to contribute a manuscript to this dedicated issue, thus honoring Professor Benet, please contact Professor Emi Nakashima (nakashima-em@pha.keio.ac.jp) for more details. It is anticipated that the issue dedicated to Professor Leslie Z. Benet will be published in September 2013.